H Wang, J Shi, Q Wang, H Li, K Cai, X Hou, T … - Cancer Immunology, Immunotherapy - Springer Abstract Purpose A new VEGF receptor fusion protein FP3 was shown to have
promising antitumor potency better than Bevacizumab. Characterization of its
immune response is essential to the safe and effective administration in ... Related articles - All 2 versions
FT Afshari, JW Fawcett - Eye, 2009 - nature.com Age-related macular degeneration is the leading cause of blindness in the
developing world. Retinal pigmented epithelium (RPE) transplantation in
subretinal space, has been assessed in various animal models of age-related ... Related articles - All 3 versions
- ►prsjournal.com AE Fung, RB Bhisitkul - British Journal of Ophthalmology, 2008 - bjo.bmj.com Ocular anti-vascular endothelial growth factor (VEGF) therapy has brought
dramatic benefits to patients with exudative age-related macular degeneration
(AMD), and promises near-term advances in other major diseases such as ... Related articles - All 5 versions